Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Stran & Company, Inc.STRN · Entity 9074 | Chief Financial Officer | November 12, 2021 | November 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Stran & Company, Inc.
Report date November 12, 2021 · Filed November 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2021-11-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-11-12 · Grant · Acquired 10,000 · Balance 10,000 F1: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.15 · Expires 2031-11-11 | Direct | 81,000 |
Reported balance
After 2021-11-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-11-12 · Grant · Acquired 81,000 · Balance 81,000 F1: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month. |
Filing footnotes · ownership attribution and instrument terms
F1: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2021 Filed Nov 16, 2021 15:39 UTC | Stran & Company, Inc. STRN · Entity 9074 | GrantEmployee Stock Option (Right to Buy) · Derivative | 81,000 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001213900-21-059819 · ownership.xml · derivative · entry 2 Rollins Christopher · CIK 0001888612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 81,000 shares Expires 2031-11-11 F1 · derivative.exercise_date: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 15:39 UTC | Stran & Company, Inc. STRN · Entity 9074 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-059819 · ownership.xml · nonDerivative · entry 1 Rollins Christopher · CIK 0001888612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: The options and restricted stock vest over a two-year period with 33% vesting immediately upon issuance and the balance (67%) vesting monthly over the following two years at a rate of 1/24 per month. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.